Democrats’ New Wave Leads Attack On Pharma At Drug Pricing Hearing
The last quarter of the four-hour hearing may be a warning of things to come for pharma if the newer guard of Democrats keeps gaining traction among voters and power in Congress.
The last quarter of the four-hour hearing may be a warning of things to come for pharma if the newer guard of Democrats keeps gaining traction among voters and power in Congress.